LprG as a chaperone of immune adjuvants
An adjuvant combination that stimulates immune activation or response includes a hydrophobic immune adjuvant and a pathogen derived lipoprotein that chaperones the hydrophobic immune adjuvant to an immune receptor.
1. A vaccine comprising:
an antigen;
a hydrophobic immune adjuvant; and
purified non-acylated or acylated Mycobacterium tuberculosis LprG lipoprotein in an amount effective to chaperone the immune adjuvant to an immune receptor, the hydrophobic immune adjuvant being a glycolipid immune adjuvant.
2. The vaccine of claim 1 , the hydrophobic immune adjuvant being lipophilic.
3. The vaccine of claim 1 , the hydrophobic immune adjuvant being at least one of a TLR agonist or TLR ligand.
4. The vaccine of claim 1 , the hydrophobic immune adjuvant being at least one of a TLR2 agonist or TLR4 agonist.